views

Describing itself as “a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments”, Kromek Group (KMK) has announced “Award of £5m bio-threat contract by UK Government”. It emphasises that it is “delighted to have been awarded this contract… Governments throughout the world are reviewing their strategies to update their defence against such threats. We believe technologies that can provide information about emerging threats in near real time will be a critical component of such strategies”, but what of a share price currently above 9p in response, approaching 12% higher?

views

Kromek Group (KMK) states that it is “delighted that our CZT detectors have been integrated into Spectrum Dynamics' VERITON-CT 400 SPECT/CT systems… the world's first digital SPECT/CT scanner for higher energy imaging”. So what of the shares currently up approaching 6% to 8.35p?

views

Previously writing on group which describes itself as “a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments” Kromek (KMK), last month I noted a new distribution agreement but asked what about financials?, and concluded continue to avoid. Now it “is pleased to announce that it has completed a fundraising of £1.14 million through the issue of convertible loan notes”.

NEWSFLOW

views

Radiation and bio-detection technology group Kromek (KMK) is “delighted to partner with Smiths Detection… to deliver our solutions to customers across North and South America”. So what of a share price response currently approaching 8% higher towards 10p?

views

Radiation and bio-detection technology group Kromek (KMK) is “pleased to have received… latest order for our D3S-ID nuclear radiation detector… from a US federal entity”. What of a current share price response up to 12.75p?...

views

Previously writing on group now describing itself as “a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments” Kromek (KMK), in July with the shares down towards 15p I reviewed “well-placed to capitalise on the substantial opportunities”, concluding still a sell. It today provides an update, with its year ended 30th April.

NEWSFLOW

NEWSFLOW

views

Kromek Group (KMK) has announced “new contracts and repeat orders across all of its target segments as commercial momentum continues to increase across the business”. Why then are the shares, heading towards 15p, currently more than 6% lower in response?...